The data suggests strong pull-through demand at the prices vendors are listing: vials sell faster than they restock
Loose stools are common, especially early in treatment, and usually settle as your body adjusts
But in real life, not everyone does
Exendin-4;OXM2;OXM;GLP-1-Derived-Peptides %glp%;%glucagon%
Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)
Hydration and electrolytes